Advertisement

Topics

Typhoid Vaccine Wyeth - Biotech, Pharma and Life Science Channel

17:16 EST 18th January 2017 | BioPortfolio

PubMed Articles [1334 Associated PubMed Articles listed on BioPortfolio]

Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review

Nonencapsulated, nontypeable Hemophilus influenzae (NTHi) remains an important cause of acute otitis and respiratory diseases in children and adults. NTHi bacteria are one of the major causes of respi...

A Survey of Parental Perception and Pattern of Action in Response to Influenza-like Illness in Their Children: Including Healthcare Use and Vaccination in Korea.

Seasonal influenza is a significant cause of morbidity and mortality of children in Korea. However, few data are available on parental perception and action toward childhood influenza. This study aime...

Proteomics: Technologies and Their Applications.

Proteomics involves the applications of technologies for the identification and quantification of overall proteins present content of a cell, tissue or an organism. It supplements the other "omics" ...

Zika Virus Molecular Biology and Perspectives for Vaccine Development: A Review.

Nicolau syndrome induced by intramuscular injection of a hexavalent vaccine in a 6-month-old girl.

Nicolau syndrome, also known as embolia cutis medicamentosa or livedo-like dermatitis, is a sudden tissue necrosis, a rare complication of intramuscular injection of some drugs. We report a case of a ...

Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.

Inactivated influenza vaccination induces a hemagglutinin-specific antibody response to the strain used for immunization. Annual vaccination is strongly recommended for health care personnel. However,...

Persistence of Antibody to Hepatitis A Virus 20 Years After Receipt of Hepatitis A Vaccine in Alaska.

Hepatitis A vaccine is recommended for children ≥1 year old to prevent hepatitis A virus (HAV) infection. However the duration of vaccine-induced immunity is unknown. We evaluated a cohort of Alaska...

RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.

Major progress is being made in vaccines against Respiratory Syncytial Virus (RSV), with multiple vaccine candidates currently in the clinical phase of development. Making an investment case for publi...

Hispanic mothers' beliefs regarding HPV vaccine series completion in their adolescent daughters.

Rates of human papillomavirus (HPV) vaccine series completion among adolescent Hispanic females in Texas in 2014 (∼39%) lag behind the Healthy People 2020 goal (80%). This qualitative study identifi...

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.

Health decision makers need to know the impact of the development of a new intervention on the public health and health care costs so that they can plan for economic and financial objectives. The aim ...

News Articles [2241 Associated News Articles listed on BioPortfolio]

ChronTech Pharma AB Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryChronTech Pharma AB ChronTech Pharma is a pharmaceutical company that develops drugs. The company develops and commercializes drugs for chronic disease that are based on proprietary and patente...

Serum Institute of India Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummarySerum Institute of India Ltd SIIL is a drug development and manufacturing company that manufactures and markets vaccines and biologicals. The company offers polio vaccine, diphtheria, tetanus, ...

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Revision: 27, Authorised

Senators on key panel reject Donald Trump’s skepticism about vaccines

Following Trump’s meeting with a vaccine skeptic, STAT contacted all 23 members of a key Senate health committee for their views on vaccine safety.

Zika Virus Vaccines Market Expected to Reach $18,697 Million, by 2022, Globally

PORTLAND, Oregon and PUNE, India, January 18, 2017 /PRNewswire/ -- A new report published by Allied Market Research, titled, "Zika Virus Vaccines Market-Global Opportunity Analysis and Industry Fo...

Adimmune Corp 4142 Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryAdimmune Corp Adimmune is a pharmaceutical company that manufactures vaccines, diagnostics, and biological products for various diseases. The company offers products such as Japan encephalitis ...

Global Influenza Vaccines - World Industry Market Outlook 2017-2027

Visiongain Ltd, January 18, 2017 /PRNewswire/ -- Forecasts for Trivalent Influenza Vaccines (TIV) & Quadrivalent Influenza Vaccines (QIV), Analysis of Pipeline Developments For Fluzone / VaxiG...

Vaccines: Is More Oversight Needed?

(MedPage Today) -- Is a vaccine safety commission a step forward or back?

Top EU-Groups Join Forces in Quest for Vaccine

Themis Measles Vector Technology Central to Action Plan Leading European research groups pool their expertise for the fast development of an effective and affordable vaccine against the Zika virus. Su...

California’s vaccine mandate is working. More states should adopt it.

On June 30, 2015, California’s Gov. Jerry Brown signed into law Senate Bill 277 (SB277), which tightened requirements so that parents could no longer opt out of vaccinating their children if they we...

Events [0 Results]

None

Companies [99 Associated Companies listed on BioPortfolio]

IDT Biologika and CMC Biologics

IDT Biologika is an innovative life science company headquartered in Dessau, Germany with extensive expertise in research, development and manufacturing of vaccines, and in additi...

TOMTEC

Tomtec has succeeded since 1967 by working with its clients to help solve their liquid handling needs. From 1967 to 1981, the Company had essentially one employee, Tom Astle. From 1967 to 1971, the Co...

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a pate...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allo...

VaxAlta Inc.

VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, effecti...

IDT Biologika

IDT Biologika is an innovative, privately-held life science company with more than 94 years history and expertise in Research, Development and Manufacturing of biologics for the g...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company with operations in the United States and Europe. The Company is engaged in the research, clinical and commercial development of ...

Clinical Trials [2811 Associated Clinical Trials listed on BioPortfolio]

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

Low Birth Weight Follow-up

The Randomized Control Trail included 4,172 low-birth weight children between February 2008 and September 2013 in Bissau. The children who were included in the RCT and who are living in th...

Kinetics of B-Cell Responses to Live Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

This pilot study will investigate the peak of the post-immunization B-cell responses following vaccination with live, attenuated influenza vaccine in healthy children 2 years of age from b...

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

In this exploratory study, investigators will be looking at immune response differences between age groups and between the two different influenza vaccines given to identical twins and vac...

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

In this exploratory study, investigators will be looking at immune response differences between age groups and between the two different vaccines given to identical twins and vaccine-naive...

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

This study is a multi-center, randomized, double-blind Phase III Clinical trial. The purpose of this study is to assess the immunogenicity and safety of the quadrivalent cell culture-deriv...

Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans

This study covers the first trial of the Crimean-Congo Hemorrhagic fever virus (CKKA) vaccine on humans (healthy volunteers), which has been developed in Turkey and has completed preclinic...

Reactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine

The study is a single centre, phase I, open, randomized, by intranasal and sublingual application trial that explored the safety and immunogenicity of 2 doses (Day 1 and Day 21) TB/FLU-01L...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.

Quick Search
Advertisement
 
review and buy Typhoid Vaccine Wyeth market research data and corporate reports here

Channels Quicklinks